A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Palbociclib Impurity 33 - Request Quote

Picture of Palbociclib Impurity 33

Palbociclib Impurity 33

SZ CAT No:SZ-P015041
CAS No
NA
Mol.F.
C33H43N7O4
Mol.Wt.
601.8
Inv. Status
Synthesis on demand

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Palbociclib Impurity 33 is chemically Tert-butyl 4-(6-((6-(1-(but-3-en-1-yloxy)vinyl)-8-cyclopentyl-5-methyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-2-yl)amino)pyridin-3-yl)piperazine-1-carboxylate. Palbociclib Impurity 33 is supplied with detailed characterization data compliant with regulatory guideline. Palbociclib Impurity 33 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Palbociclib.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

buy high quality Palbociclib Impurity 33

Purchase Palbociclib Impurity 33

Palbociclib Impurity 33 suppliers

Palbociclib Impurity 33 manufacturers

Palbociclib Impurity 33 price

Order Palbociclib Impurity 33

Enquire Palbociclib Impurity 33

Palbociclib Impurity 33 cost

Palbociclib Impurity 33 Supplier

Palbociclib Impurity 33 Distributor

Palbociclib Impurity 33 for Method Validation

Palbociclib Reference Standard

Palbociclib Impurity 33 for ANDA Filing

Palbociclib Impurity 33 for Forced Degradation Studies

Palbociclib Impurity 33 Identification Standards

Palbociclib Impurity 33 for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,